VASCULAR ENDOTHELIUM AS AN ENDOCRINE ORGAN

1 Gimbrone MA. In: Vascular Endothelium in Haemostasis and Thrombosis. Contemporary Issues in Haemostasis and Thrombosis. Vol. 2. Edinburgh: Churchill Livingstone; 1987; 1-13.

2 Furchgott RF Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:373-6.

3 Palmer RM AG Ferrige Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-6.

4 Waldman SA Murad F. Cyclic GMP synthesis and function. Pharma Rev 1987; 39:163-96.

5 Gryglewski RJ RM Botting Vane JR. Mediators produced by the endothelial cell. Hypertension 1988; 12:530-48.

6 Myers PR Tanner MA. Vascular endothelial cell regulation of extracellular matrix collagen: Role of nitric oxide. Arterioscl Thromb Vasc Biol 1998; 18(5):717-22.

7 Vallance P J Collier Moncada S. Effects of endotheliumderived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2(8670):997-1000.

8 Rees DD RMJ Palmer Moncada S. Role of endotheliumderived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989; 86:3375-8.

9 Vane JR EE Änggård Botting RM. Regulatory functions of the vascular endothelium. N Eng J Med 1990; 323:27-36.

10 Okada K Y Miyazaki Takeda J Conversion of big endothelin-1 by membrane-bound metalloendopeptidase in cultured bovine endothelial cells. Biochem Biophys Res Commun 1990; 171:1192-8.

11 Inoue A M Yanagisawa Kimura S. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by their separate genes. Proc Natl Acad Sci USA 1989; 86:2863-7.

12 Lidbury PS C Thiemermann Thomas GR Endothelin-3: selectivity as an anti-aggregatory peptide in vivo. Eur J Pharma 1989; 166:335-8.

13 Arai H S Hori Aramori I Cloning and expression of cDNA encoding an endothelin receptor. Nature 1990; 348:730-2.

14 Sakurai T M Yanagisawa Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci 1992; 13:103-8.

15 Eguchi S Y Hirata Imai T Phenotypic changes of endothelin receptor subtype in cultured rat vascular smooth muscle cells. Endocrinology 1994; 134:222-8.

16 Thiemermann C PS Lidbury Thomas GR Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in anaesthetized rabbit. Br J Pharmacol 1989; 13(5):S138-41.

17 Whittle BJR Moncada S. The endothelin explosion. A pathophysiological reality or a biological curiosity. Circulation 1990; 8:2022-5.

18 Widimsky J K Horky Plasma endothelin-1 Dvorakova J. mild 2 levels in and severe hypertension. J Hypertension 1991; 9(6):S194-5.

19 Florijn KW FH Derkx Visser W Elevated plasma levels of endothelin in pre-eclampsia. J Hypertension 1991; 9(6): S166-7.

20 Kohno M K Yasunari Murakawa KI Plasma immunoreactive endothelin in essential hypertension. Am J Med 1990; 88:614-8.

21 Naruse M N Nakamura Naruse K Plasma immunoreactive endothelin levels are increased in hemodialysis patients with hypertension following erythropoietin therapy. Hypertens Res 1992; 15:11-6.

22 Mihatsch MJ JF Bach Coovadia HF Cyclosporinassociated nephropathy in patients with autoimmune diseases. Klin Wochenschr 1988; 66:43-7.

23 Komuro I H Kurihara Sugiyama T Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988; 238:249-52.

24 Boulanger CM FC Tanner Bea ML Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 1992; 70(6):1191-7.

25 Haak T W Marz Jungmann E Elevated endothelin levels in patients with hyperlipoproteinemia. Clin Invest 1994; 72:580-4.

26 Haak T E Jungmann Raab C Elevated endothelin-1 levels after cigarette smoking. Metabolism 1994; 43(3):267-9.

27 Lerman A BS Edwards Hallett JW Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Eng J Med 1991; 325:997-1001.

28 Yasuda M M Kohno Tahara A Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J 1990; 18:38-43.

29 Miyauchi T M Yanagisawa Tomizawa T Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 1989; 2(8653):53-4.

30 Rodeheffer RJ A Lerman Heublein DM Concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc 1992; 67:719-24.

31 Shichiri M H Kato Marumo F Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension 1997; 30(5):1198-203.

32 Pernow J A Franco-Cereda Matran R Effect of endothelin-1 on regional vascular resistances in the pig. J Cardiovasc Pharmacol 1989; 13(5):S205-6.

33 Hocher B C Thöne-Reineke Rohmeiss P Endothelin-1 transgenic mice develop renal cysts, interstitial fibrosis and glomerulosclerosis but not hypertension. J Clin Invest 1997; 99(6):1380-9.

34 Änggård E S Galton Rae G The fate of radioiodinated endothelin-1 and endothelin-3 in the rat. J Cardiovasc Pharma 1989; 13(5):S46-9.

35 Kpmatsu Y K Nakao Itoh H Vascular natriuretic peptide. Lancet 1992; 340:622.

36 Suga S K Nakao Itoh H Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-ß. Possible existence of “vascular natriuretic peptide system”. J Clin Invest 1992; 90:1145-9.

37 Koller KJ DG Lowe Bennett GL Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 1991; 252:120-3.

38 Suga S K Nakao Hosoda K Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 1992; 130:229-39.

39 Stingo AJ AL Clavell Heublein DM Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol 1992; 263:H1318-21.

40 Furuya M M Takehisa Minamitake Y Novel natriuretic peptide, CNP, potently stimulates cGMP production in raty cultured vascular smooth muscle cells. Biochem Biophys Res Commun 1990; 170:201-8.

41 Furuya M K Aisaka Miyazaki T C-type natriuretic peptide inhibits intimal thickening after vascular injury. Biochem Biophys Res Commun 1993; 193:248-53.

42 Hama N H Itoh Shirakami G Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem Biophys Res Commun 1994; 198:1177-82.

43 Kohno M K Yasunari Yokokawa K Inhibition of atrial and brain natriuretic peptide of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells. J Clin Invest 1991; 87:1999-2004.

44 Kohno M T Horio Yokokawa K C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3’, 5’-monophosphate. Hypertension 1992; 19:320-25.

45 Yokokawa K M Kohno Yasunari K Endothelin-3 regulates endothelin-1 production in cultured human endothelial cells. Hypertension 1991; 18:304-15.

46 Eguchi S Y Hirata Imai T C-type natriuretic peptide up-regulates endothelin type B receptor in cultured rat vascular smooth muscle cells. Hypertension 1994; 23(2): 936-40.

47 Willis AL DL Smith Vigo C Effects of prostacyclin and orally active stable mimetic agent RS-93427-007 on basic mechanisms of atherogenesis. Lancet 1986; 2:682-3.

48 Nilsson L C Banfi Diczfalusy U Unsaturated fatty acids increase plasminogen activator inhibitor-1 expression in endothelial cells. Atheroscl Thromb Vasc Biol 1998; 18(11):1679-85.

49 Yamagishi S T Kawakami Fujimori H Insulin stimulates the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. Microvasc Res 1999; 57(3):329-39.

50 Meigs JB MA Mittleman Nathan DM Hyperinsulinemia, hyperglycemia, and impaired hemostasis. The Framingham offspring study. JAMA 2000; 283(2):221-8.

51 Nishimura H H Tsuji Masuda H Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells. Thrombosis Haemostasis 1997; 77(6):1189-95.

52 Steins MB T Padro Li C-X Overexpression of tissuetype plasminogen activator in atherosclerotic human coronary arteries. Atherosclerosis 1999; 145(1):173-80.

53 Brown NJ JV Gainer Stein CM Bradykinin stimulates tissue plasminogen activator release in human vasculature. Hypertension 1999; 33(6):1431-5.

54 Stein CM N Brown Vaughan DE Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. J Am Coll Cardiol 1998; 32: 117-22.

55 Nolly H Release of endothelial-derived kallikrein Nolly A. , kininogen and kinins. Biol Res 1998; 31(3):169-74.

56 Furie B Furie BC. P-selectin induction of tissue factor biosynthesis and expression. Haemostasis 1996; 26(1): 60-5.

57 Chong BH B Murray Berndt MC Plasma P-selectin is increased in thrombotic consumptive disorders. Blood 1994; 83:1535-41.

58 Jilma B P Fasching Ruthner C Elevated circulating Pselectin in insulin dependent diabetes mellitus. Thromb Haemostas 1996; 76:328-32.

59 Blann AD EB Faragher McCollum CN. Increased soluble Pselectin in ischaemic heart disease: a new marker for the progression of atherosclerosis. Blood Coag Fibrinolysis 1997; 8:383-90.

60 Koch AE MM Halloran Haskell CJ Angiogenesis is mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995; 376:517.

61 Bevilacqua MP JS Pober Mendrick DL Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987; 84:9238.

62 Blann AD J Arniral McCollum CN. Soluble endothelial cell markers and adhesion molecules in ischaemic heart disease. Br J Haematol 1996; 95:263-5.

63 Elhadd TA G Kirk McLaren M High levels of cell adhesion molecules, sE-selectin and sICAM-1 as markers of endothelial dysfunction in children, adolescents and young adults with IDDM (Abstract). Diabetes 1997; 46:112A.

64 Belch JJF JW Shaw Kirk G The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergiong percutaneous transluminal angioplasty. Circulation 1997; 95:2298-302.

65 Ribau JCO SJ Hadcock Teoh K Endothelial adhesion molecule expression is enhanced in the aorta and interna mammary artery of diabetic patients. J Surg Res 1999; 85(2):225-33.

66 Ridker PM CH Hennekens Roitman-Johnson B Plasma concentration of intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351(9096):88-92.

67 Weber C W Erl Weber KSC Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions. Clin Chem Lab Med 1999; 37(3):243-51.

68 Manduteanu I M Voinea Serban G High glucose induces enhanced monocyte adhesion to valvular endothelial cells via a mechanism involving ICAM-1, VCAM-1 and CD18. Endothelium: J Endothelial Res 1999; 6(4):315-24.

69 Pastore L A Tessitore Martinotti S Angiotensin II stimulates intercellular adhesion molecule –1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 1999; 100(15):1646-52.

70 Voisard R M Osswald Baur R Expression of intercellular adhesion molecule-1 in human coronary endothelial and smooth muscle cells after stimulation with tumor necrosis factor-alpha. Coronary Artery Dis 1998; 9(11):737-45.

71 Marathe S SL Schissel Yellin MJ Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling. J Biol Chem 1998; 273(7):4081-8.

72 Michibata H M Mukoyama Tanaka I Autocrine/paracrine role of adrenomedullin in cultured endothelial and mesangial cells. Kidney Int 1998; 53(4):979-85.

73 Iwashima Y T Sato Watanabe K Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy. Diabetes 1990; 39:983-8.

74 Bussolino F Camussi G. Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties. Eur J Biochem 1995; 229(2):327-37.

75 Lindahl AK PM Sandset Abildgaard U. The present status of tissue factor pathway inhibitor. Blood Coag Fibrinolysis 1992; 3:439-49.

76 Leurs PB R Van Oerle Hamulyak K Tissue factor pathway inhibitor activity in patients with IDDM. Diabetes 1995; 44:80-4.

77 Yokoyama H B Myrup Rossing P Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy. Diabetes Care 1996; 19:441-5.

78 Boneu B M Abbal Plante J Factor VIII complex and endothelial damage. Lancet 1975; 1:1430.

79 Kessler L ML Wiesel Attali P Von Willebrand factor in diabetic angiopathy. Diabetes Metab 1998; 24(4):327-36.